期刊文献+

胃癌骨转移相关因素探讨 被引量:2

Correlative factors of skeletal metastases of gastric carcinoma
下载PDF
导出
摘要 为探讨胃癌骨转移及其影响因素,对131例胃癌患者进行了核素骨显像检查,对骨转移与时间的关系进行了前瞻性研究,对影响骨转移的因素进行了分析。结果:胃癌骨转移的发生率达412%,随时间的增加有明显增高的趋势;胃癌骨转移与临床分期(r=0.965)和病理形态学类型(r=0.958)有关(P均<0.05);与肿瘤的大小(r=0.730)、部位(r=-0.513)和病理组织学类型(r=-0.673)无关(P均>0.05);临床Ⅲ、Ⅳ期与Ⅰ、Ⅱ期胃癌间(χ2=1199),浸润、扩散型与赘生、溃疡型胃癌间(χ2=14.45)骨转移的发生有显著性差异(P均<0.01)。结果提示:胃癌特别是临床Ⅲ、Ⅳ期和(或)浸润与扩散型患者应常规定期行核素骨显像检查。 ? To study the influencing factors for skeletal metastases of gastric carcinoma, 131 patients with gastric carcinoma were examined with nuclear skeletal imaging.Prospective study was made on the relation between bone metastases and time,and the influencing factors of skeletal metastases were statistically analyzed.41.2% patients with gastric carcinoma had skeletal metastases,and an increasing tendency was observed with the time passing by.The skeletal metastases was correlated with the clinical stages(r=0.965,P<0.05) and the pathomorphologic types(r=0.958,P<0.05) but not with the tumor sizes (r=0.730,P>0.05),the positions(r=-0.513,P>0.05)and the pathohistologic types(r=-0.673,P>0.05).The skeletal metastases had significant difference between the clinical stage Ⅲ and Ⅳ,and stage Ⅰ and Ⅱ (χ2=11.9,P<0.01),and between the pathomorphologic types of diffusion and invasion, and the types of polyposis and ulcer (χ2=14.45,P<0.01).Nuclear skeletal imaging should be regularely and routinly performed in patients with gastric carcinoma,especially with clinical stage of Ⅲ and Ⅳ,or/and pathomorphologic types of diffusion and invasion.
出处 《河南医科大学学报》 1997年第4期53-55,共3页 Journal of Henan Medical University
关键词 胃肿瘤 核素骨显像 转移性骨肿瘤 gastric carcinoma nuclear skeletal imaging metastastic bone tumor
  • 相关文献

参考文献3

共引文献12

同被引文献10

  • 1Inberg MV, Laur6n P, Vuori J,et al. Prognosis in intestinaltype and diffuse gastric carcinoma with special reference tothe effect of the stromal reaction [J]. Acta Chir Scand,1973,139(3): 273-278.
  • 2wEtoh T, Baba H, Taketomi A, et al. Diffuse bone metastasiswith hematologic disorders from gastric cancer: clinicopathological features and prognosis [J]. Oncol Rep, 1999,6 (3) :601-605.
  • 3Yoshikawa K, Kitaoka H. Bone metastasis of gastric cancer[J]. Jpn J Surg, 1983, 13(3): 173-176.
  • 4Nishidoi H, Koga S. Clinicopathological study of gastric cancerwith bone metastasis [J]. Gan To Kagaku Ryoho, 1987,14(5): 1717-1722.
  • 5Sudo H, Takagi Y, Katayanagi S, et al. Bone metastasis ofgastric cancer[J]. Gan To Kagaku Ryoho, 2006, 33 (8):1058-1060.
  • 6Etoh T, Baba H, Taketomi A, et al. Sequential methothrex-tate and 5-fruororacil therapy for diffuse bone metastasis fromgastric cancer [J]. Anticancer Res, 1998, 18 (3) : 2085-2088.
  • 7Hironaka SI, Boku N, Ohtsu A, et al. Sequential methotrex-ate and 5-fluorouracil therapy for gastric cancer patients withbone metastasis [J]. Gastric Cancer, 2000,3( 1 ) : 19-23.
  • 8孙达.放射性核素骨显像[M].杭州:浙江大学出版社,2000.32-33.
  • 9荣维淇,吴健雄.胃癌骨转移的诊断与综合治疗[J].中国骨肿瘤骨病,2003,2(2):83-87. 被引量:6
  • 10朱金水.胃癌的治疗现状[J].中国临床医学,2004,11(2):131-134. 被引量:29

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部